Triple Therapy for Idiopathic Pulmonary Fibrosis

Thorax - United Kingdom
doi 10.1136/thoraxjnl-2012-202518
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Cell Therapy in Idiopathic Pulmonary Fibrosis†

Medical Sciences
2018English

Idiopathic Pulmonary Fibrosis

Pulmonologiya
PulmonaryRespiratory Medicine
2015English

Idiopathic Pulmonary Fibrosis

2020English

Micro RNAs: The Future of Idiopathic Pulmonary Fibrosis Therapy

Cell Biochemistry and Biophysics
MedicineBiochemistryCell BiologyBiophysics
2014English

Diagnostic Criteria for Idiopathic Pulmonary Fibrosis

Lancet Respiratory Medicine,The
PulmonaryRespiratory Medicine
2018English

Emerging Drugs for Idiopathic Pulmonary Fibrosis

Expert Opinion on Emerging Drugs
Pharmacology
2011English

Epigenomics of Idiopathic Pulmonary Fibrosis

American Journal of Respiratory and Critical Care Medicine
PulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2012English

Idiopathic Pulmonary Fibrosis and Pirfenidone

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2010English

Focus on Idiopathic Pulmonary Fibrosis

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy